S&CO Inc’s Eli Lilly LLY Stock Holding History

S&CO Inc’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.7M	Buy	22,300 +781	+4%	+$798K	1.55%	18
2026 Q1	$19.8M	Buy	21,519 +1,310	+6%	+$1.33M	1.23%	23
2025 Q4	$21.7M	Buy	20,209 +181	+0.9%	+$173K	1.35%	21
2025 Q3	$15.3M	Buy	20,028 +7,928	+66%	+$5.9M	0.94%	30
2025 Q2	$9.43M	Buy	12,100 +440	+4%	+$342K	0.6%	43
2025 Q1	$9.63M	Buy	11,660 +5,550	+91%	+$4.62M	0.65%	41
2024 Q4	$4.72M	Hold	6,110	–	–	0.32%	70
2024 Q3	$5.41M	Sell	6,110 -40	-0.7%	-$36K	0.35%	63
2024 Q2	$5.57M	Sell	6,150 -525	-8%	-$420K	0.39%	57
2024 Q1	$5.19M	Sell	6,675 -1,150	-15%	-$818K	0.37%	60
2023 Q4	$4.56M	Sell	7,825 -670	-8%	-$391K	0.35%	64
2023 Q3	$4.56M	Hold	8,495	–	–	0.37%	58
2023 Q2	$3.98M	Sell	8,495 -35	-0.4%	-$14.7K	0.32%	62
2023 Q1	$2.93M	Sell	8,530 -115	-1%	-$38.8K	0.25%	71
2022 Q4	$3.16M	Sell	8,645 -15	-0.2%	-$5.32K	0.28%	67
2022 Q3	$2.8M	Sell	8,660 -80	-0.9%	-$25.3K	0.25%	71
2022 Q2	$2.83M	Sell	8,740 -50	-0.6%	-$15K	0.24%	73
2022 Q1	$2.52M	Hold	8,790	–	–	0.18%	88
2021 Q4	$2.43M	Hold	8,790	–	–	0.17%	95
2021 Q3	$2.03M	Sell	8,790 -50	-0.6%	-$12.3K	0.16%	96
2021 Q2	$2.03M	Hold	8,840	–	–	0.16%	100
2021 Q1	$1.65M	Hold	8,840	–	–	0.14%	98
2020 Q4	$1.49M	Hold	8,840	–	–	0.13%	102
2020 Q3	$1.31M	Sell	8,840 -155	-2%	-$24K	0.13%	101
2020 Q2	$1.48M	Hold	8,995	–	–	0.16%	93
2020 Q1	$1.25M	Hold	8,995	–	–	0.17%	86
2019 Q4	$1.18M	Hold	8,995	–	–	0.12%	97
2019 Q3	$1.01M	Hold	8,995	–	–	0.11%	109
2019 Q2	$997K	Hold	8,995	–	–	0.11%	108
2019 Q1	$1.17M	Hold	8,995	–	–	0.13%	99
2018 Q4	$1.04M	Hold	8,995	–	–	0.13%	99
2018 Q3	$965K	Hold	8,995	–	–	0.11%	112
2018 Q2	$768K	Hold	8,995	–	–	0.09%	119
2018 Q1	$696K	Hold	8,995	–	–	0.09%	115
2017 Q4	$760K	Hold	8,995	–	–	0.09%	108
2017 Q3	$769K	Buy	8,995 +100	+1%	+$8.2K	0.1%	109
2017 Q2	$732K	Buy	8,895 +1,325	+18%	+$108K	0.1%	109
2017 Q1	$637K	Hold	7,570	–	–	0.09%	109
2016 Q4	$557K	Hold	7,570	–	–	0.08%	113
2016 Q3	$608K	Hold	7,570	–	–	0.09%	113
2016 Q2	$596K	Buy	7,570 +900	+13%	+$67.8K	0.09%	110
2016 Q1	$480K	Hold	6,670	–	–	0.08%	108
2015 Q4	$562K	Hold	6,670	–	–	0.09%	107
2015 Q3	$558K	Hold	6,670	–	–	0.1%	108
2015 Q2	$557K	Hold	6,670	–	–	0.08%	108
2015 Q1	$485K	Hold	6,670	–	–	0.07%	110
2014 Q4	$460K	Hold	6,670	–	–	0.07%	110
2014 Q3	$433K	Buy	+6,670	New	+$422K	0.07%	107

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

S&CO Inc's LLY Position: Q2 2026 in Review

S&CO Inc increased its Eli Lilly (LLY) stake by 3.6% in Q2 2026, buying an estimated $798K and bringing the position to 22,300 shares worth $26.7M. The position accounts for 1.55% of the portfolio, ranked #18.

S&CO Inc first reported a position in LLY in Q3 2014 and has held it in 48 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

S&CO Inc held 22,300 shares of Eli Lilly worth $26.7M as of Q2 2026.
S&CO Inc bought 781 Eli Lilly shares in Q2 2026, an estimated $798K.
Eli Lilly made up 1.55% of S&CO Inc's portfolio in Q2 2026, its #18 holding.
S&CO Inc first reported a position in Eli Lilly in Q3 2014 and has held it in 48 quarters since.
4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on S&CO Inc's 13F filing for Q2 2026, filed 6 Aug 2026.